Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Savic

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Genome Research|October 22, 2015
Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein beta binding sitesDaniel Savic, Brian S Roberts, Julia B Carleton, et al.
Molecular Cell|October 1, 2013
Distinct properties of cell-type-specific and shared transcription factor binding sitesJason Gertz, Daniel Savic, Katherine E Varley, et al.
Cell Reports|October 31, 2019
Batf Pioneers the Reorganization of Chromatin in Developing Effector T Cells via Ets1-Dependent Recruitment of CtcfDuy Pham, Carson E Moseley, Min Gao, et al.
The Journal of Clinical Investigation|July 15, 2025
The NUDIX hydrolase NUDT5 regulates thiopurine metabolism and cytotoxicityMaud Maillard, Rina Nishii, Hieu S Vu, et al.
Genome Medicine|July 13, 2016
Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferationDaniel Savic, Ryne C Ramaker, Brian S Roberts, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemiaBrennan P Bergeron, Kelly R Barnett, Kashi Raj Bhattarai, et al.
Blood Advances|June 8, 2023
Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemiaBrennan P Bergeron, Kelly R Barnett, Kashi Raj Bhattarai, et al.
Journal of the National Cancer Institute|May 16, 2022
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic LeukemiaXujie Zhao, Maoxiang Qian, Charnise Goodings, et al.
Nature Communications|September 14, 2022
Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemiaXujie Zhao, Ping Wang, Jonathan D Diedrich, et al.
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Genome Research|October 22, 2015
Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein beta binding sitesDaniel Savic, Brian S Roberts, Julia B Carleton, et al.
Molecular Cell|October 1, 2013
Distinct properties of cell-type-specific and shared transcription factor binding sitesJason Gertz, Daniel Savic, Katherine E Varley, et al.
Cell Reports|October 31, 2019
Batf Pioneers the Reorganization of Chromatin in Developing Effector T Cells via Ets1-Dependent Recruitment of CtcfDuy Pham, Carson E Moseley, Min Gao, et al.
The Journal of Clinical Investigation|July 15, 2025
The NUDIX hydrolase NUDT5 regulates thiopurine metabolism and cytotoxicityMaud Maillard, Rina Nishii, Hieu S Vu, et al.
Genome Medicine|July 13, 2016
Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferationDaniel Savic, Ryne C Ramaker, Brian S Roberts, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemiaBrennan P Bergeron, Kelly R Barnett, Kashi Raj Bhattarai, et al.
Blood Advances|June 8, 2023
Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemiaBrennan P Bergeron, Kelly R Barnett, Kashi Raj Bhattarai, et al.
Journal of the National Cancer Institute|May 16, 2022
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic LeukemiaXujie Zhao, Maoxiang Qian, Charnise Goodings, et al.
Nature Communications|September 14, 2022
Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemiaXujie Zhao, Ping Wang, Jonathan D Diedrich, et al.
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
Pageof 4